6 Articles found
Genomadix Articles
-
TAILOR-PCI Proves Genotype-guided Antiplatelet Therapy Reduces MACE
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). Genomadix’s FDA-cleared rapid RX CYP2C19 genotyping test was used to ...
-
How often should you test for Legionella?
If you’re reading this post, you’ve likely decided that testing for Legionella in your building is important for protecting your occupants. If you’re not aware of the dangers of Legionella bacteria, our recent blog post can give ...
-
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results
Genomadix’s European Scientific Advisory Board Comments on TAILOR-PCI Results *The largest genetics-based clinical trial in cardiology history supported by Genomadix’s Precision Medicine technology * The results of the TAILOR-PCI trial ...
-
A Conversation with Prof. Davide Capodanno, M.D., Ph.D. on the Landmark TAILOR-PCI Clinical Trial Results
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient ...
-
Genomadix’s Legionella Test used by CDC for Legionnaires’ Outbreak
The CDC chose Genomadix Bioscience, an Ottawa-based biotechnology company, to assist with a Legionnaires’ outbreak in Chesterfield, VA. The Virginia Department of Health (VDH) identified an increase in Legionnaires’ disease cases in ...
-
The Hidden Dangers of Legionella Bacteria in Workplace Water Systems
Has your building shut down or reduced operations due to COVID-19? If so, you may be putting your employees or building occupants in danger, especially if your water system has been stagnant, or has had low flow during the shutdown. With the recent ...